Cyprumed and MSD Agree to Develop Oral Peptide Formulations and CDMO Meribel Pharma Solutions Launches

Meribel Pharma Solutions aims to elevate pharma services

A new, mid-size Contract Development Manufacturing Organisation (CDMO), Meribel Pharma Solutions has launched with an integrated network across Europe, led by a team of industry experts on a mission to deliver the highest quality solutions.

Cyprumed and MSD Agree to Develop Oral Peptide Formulations and CDMO Meribel Pharma Solutions Launches

Cyprumed and MSD signed a nonexclusive license and option agreement to develop oral formulations of MSD’s peptides using Cyprumed’s innovative drug delivery technology. MSD gains nonexclusive global rights to Cyprumed’s oral peptide delivery platform for an undisclosed number of targets. The agreement also grants MSD the option to exclusively license Cyprumed’s technology for use with individual targets. Cyprumed will be eligible to receive up t…

Meribel Pharma Solutions Launches as CDMO with Ten Manufacturing Sites Across Europe.

Meribel Pharma Solutions has entered the contract devel […] The post Meribel Pharma Solutions Launches as CDMO with Ten Manufacturing Sites Across Europe. first appeared on GeneOnline News. The post Meribel Pharma Solutions Launches as CDMO with Ten Manufacturing Sites Across Europe. appeared first on GeneOnline News.

Meribel Pharma Solutions launches as mid-sized European CDMO with multi-country network - Express Pharma

A new mid-sized Meribel Pharma Solutions, has officially launched operations across Europe. The company enters the market with ten manufacturing sites and three drug development service locations spread across France, Spain and Sweden. The launch follows the acquisition of the Synerlab Group and seven European manufacturing facilities from Recipharm in 2023. Meribel Pharma Solutions is now positioned as a pan-European CDMO serving customers with…